These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 8916562)
1. Prescribing practices for the management of headache in Newfoundland and Labrador. Furlong S; Pryse-Phillips W; Crowley M; Turner CJ Headache; 1996 Oct; 36(9):542-6. PubMed ID: 8916562 [TBL] [Abstract][Full Text] [Related]
2. Patterns of ergotamine and sumatriptan use in the Netherlands from 1991 to 1997. Rahimtoola H; Egberts AC; Buurma H; Tijssen CC; Leufkens HG Cephalalgia; 2001 Jun; 21(5):596-603. PubMed ID: 11472386 [TBL] [Abstract][Full Text] [Related]
3. Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data. Gaist D Cephalalgia; 1999 Oct; 19(8):735-61. PubMed ID: 10570730 [TBL] [Abstract][Full Text] [Related]
5. Is overuse of sumatriptan a problem? A population-based study. Gaist D; Hallas J; Sindrup SH; Gram LF Eur J Clin Pharmacol; 1996; 50(3):161-5. PubMed ID: 8737753 [TBL] [Abstract][Full Text] [Related]
6. Use of sumatriptan in Denmark in 1994-5: an epidemiological analysis of nationwide prescription data. Gaist D; Andersen M; Aarup AL; Hallas J; Gram LF Br J Clin Pharmacol; 1997 Apr; 43(4):429-33. PubMed ID: 9146856 [TBL] [Abstract][Full Text] [Related]
7. Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headaches. Gershovich OE; Billups SJ; Delate T; Hoffman CK; Carroll N J Manag Care Pharm; 2006 Apr; 12(3):246-53. PubMed ID: 16623609 [TBL] [Abstract][Full Text] [Related]
8. [Patterns of prescription and usage of triptans in Alsace (France): misuse is frequent and avoidable]. Perearnau P; Vuillemet F; Schick J; Weill G Rev Neurol (Paris); 2006 Mar; 162(3):347-57. PubMed ID: 16585890 [TBL] [Abstract][Full Text] [Related]
9. Effect of autogenic training on drug consumption in patients with primary headache: an 8-month follow-up study. Zsombok T; Juhasz G; Budavari A; Vitrai J; Bagdy G Headache; 2003 Mar; 43(3):251-7. PubMed ID: 12603644 [TBL] [Abstract][Full Text] [Related]
10. The disparity in access to new medication by type of health insurance: lessons from Germany. Krobot KJ; Miller WC; Kaufman JS; Christensen DB; Preisser JS; Ibrahim MA Med Care; 2004 May; 42(5):487-91. PubMed ID: 15083110 [TBL] [Abstract][Full Text] [Related]
11. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group. Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168 [TBL] [Abstract][Full Text] [Related]
12. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone. Cleland PG; Barnes D; Elrington GM; Loizou LA; Rawes GD Eur Neurol; 1997; 38(1):31-8. PubMed ID: 9252796 [TBL] [Abstract][Full Text] [Related]